Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis

Journal of Internal Medicine

Volumn 266, Issue 3, 2009, Pages 296-301

  Pongratz, G ^a   Lindner, J ^b   Modrow, S ^b   Schimanski, S ^b   Scholmerich J ^a   Fleck, M ^a,c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c Asklepios Clinic   (Germany)

Author keywords

Acute hepatitis; Autoimmune disease; Rheumatology; T cell; Virology

Indexed keywords

VIRUS DNA; VIRUS PROTEIN;

ADULT; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; ERYTHEMA INFECTIOSUM; HEPATITIS; HUMAN; IMMUNOCOMPETENCE; MALE; PARVOVIRUS; PERSISTENT INFECTION; POLYARTHRITIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ADULT; ARTHRITIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 68949103993     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02117.x     Document Type: Article

References (18)

1. Lehmann HW, Knoll A, Kuster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 2003 48 : 1631 8.
2. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996 347 : 868 9.
3. Sokal EM, Melchior M, Cornu C et al. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 1998 352 : 1739 41.
4. Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 1999 144 : 1713 24.
5. Rohrer C, Gartner B, Sauerbrei A et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008 136 : 1564 75.
6. Franssila R, Auramo J, Modrow S et al. T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity. Clin Exp Immunol 2005 142 : 53 61.
7. Lindner J, Barabas S, Saar K et al. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection. J Vet Med B Infect Dis Vet Public Health 2005 52 : 356 61.
8. Eis-Hubinger AM, Reber U, Abdul-Nour T, Glatzel U, Lauschke H, Putz U. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 2001 65 : 395 401.
9. Anderson MJ, Higgins PG, Davis LR et al. Experimental parvoviral infection in humans. J Infect Dis 1985 152 : 257 65.
10. Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995 172 : 1360 3.
11. Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ. Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. J Virol 2006 80 : 4114 21.
12. Lee WM, Brown KE, Young NS et al. Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci 2006 51 : 1712 5.
13. Wong S, Young NS, Brown KE. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 2003 187 : 1581 6.
14. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985 1 : 419 21.
15. Takahashi Y, Murai C, Shibata S et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998 95 : 8227 32.
16. Moffatt S, Tanaka N, Tada K et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 1996 70 : 8485 91.
17. Miki NP, Chantler JK. Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitro. J Gen Virol 1992 73 : 1559 62.
18. Lunardi C, Tiso M, Borgato L et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 1998 28 : 936 48.